Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Inactivated Polio and Rabies Vaccines Market by Type (Inactivated Polio Vaccine, Inactivated Rabies Vaccine), By Application (Pediatrics, Adults) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Inactivated Polio and Rabies Vaccines Market by Type (Inactivated Polio Vaccine, Inactivated Rabies Vaccine), By Application (Pediatrics, Adults) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 247997 4200 Pharma & Healthcare 377 239 Pages 4.8 (45)
                                          

Industry Growth Insights published a new data on “Inactivated Polio and Rabies Vaccines Market”. The research report is titled “Inactivated Polio and Rabies Vaccines Market research by Types (Inactivated Polio Vaccine, Inactivated Rabies Vaccine), By Applications (Pediatrics, Adults), By Players/Companies Bharat Biotech, BIO-MED, Serum Institute of India, Kedrion Biopharma, GlaxoSmithKline, Merck, Pfizer, Bharat Biotech”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Inactivated Polio and Rabies Vaccines Market Research Report

By Type

Inactivated Polio Vaccine, Inactivated Rabies Vaccine

By Application

Pediatrics, Adults

By Companies

Bharat Biotech, BIO-MED, Serum Institute of India, Kedrion Biopharma, GlaxoSmithKline, Merck, Pfizer, Bharat Biotech

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

239

Number of Tables & Figures

168

Customization Available

Yes, the report can be customized as per your need.


Global Inactivated Polio and Rabies Vaccines Industry Outlook


Global Inactivated Polio and Rabies Vaccines Market Report Segments:

The global Inactivated Polio and Rabies Vaccines market is segmented on the basis of:

Types

Inactivated Polio Vaccine, Inactivated Rabies Vaccine

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Pediatrics, Adults

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Bharat Biotech
  2. BIO-MED
  3. Serum Institute of India
  4. Kedrion Biopharma
  5. GlaxoSmithKline
  6. Merck
  7. Pfizer
  8. Bharat Biotech

Global Inactivated Polio and Rabies Vaccines Market Overview


Highlights of The Inactivated Polio and Rabies Vaccines Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Inactivated Polio Vaccine
    2. Inactivated Rabies Vaccine
  1. By Application:

    1. Pediatrics
    2. Adults
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Inactivated Polio and Rabies Vaccines Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Inactivated Polio and Rabies Vaccines Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Inactivated polio vaccine (IPV) is a vaccine that helps protect people from polio. It works by helping to prevent the virus from causing any problems in the body. IPV is given as a shot, usually in children around two years old and again when they start school. Rabies vaccines help protect people from rabies, a serious brain infection caused by viruses. They are also given as shots, usually when someone starts school or gets their first pet.

Some of the major players in the inactivated polio and rabies vaccines market are Bharat Biotech, BIO-MED, Serum Institute of India, Kedrion Biopharma, GlaxoSmithKline, Merck, Pfizer, Bharat Biotech.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Inactivated Polio and Rabies Vaccines Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Inactivated Polio and Rabies Vaccines Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Inactivated Polio and Rabies Vaccines Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Inactivated Polio and Rabies Vaccines Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Inactivated Polio and Rabies Vaccines Market Size & Forecast, 2018-2028       4.5.1 Inactivated Polio and Rabies Vaccines Market Size and Y-o-Y Growth       4.5.2 Inactivated Polio and Rabies Vaccines Market Absolute $ Opportunity

Chapter 5 Global Inactivated Polio and Rabies Vaccines Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Inactivated Polio and Rabies Vaccines Market Size Forecast by Type
      5.2.1 Inactivated Polio Vaccine
      5.2.2 Inactivated Rabies Vaccine
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Inactivated Polio and Rabies Vaccines Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Inactivated Polio and Rabies Vaccines Market Size Forecast by Applications
      6.2.1 Pediatrics
      6.2.2 Adults
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Inactivated Polio and Rabies Vaccines Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Inactivated Polio and Rabies Vaccines Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Inactivated Polio and Rabies Vaccines Analysis and Forecast
   9.1 Introduction
   9.2 North America Inactivated Polio and Rabies Vaccines Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Inactivated Polio and Rabies Vaccines Market Size Forecast by Type
      9.6.1 Inactivated Polio Vaccine
      9.6.2 Inactivated Rabies Vaccine
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Inactivated Polio and Rabies Vaccines Market Size Forecast by Applications
      9.10.1 Pediatrics
      9.10.2 Adults
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Inactivated Polio and Rabies Vaccines Analysis and Forecast
   10.1 Introduction
   10.2 Europe Inactivated Polio and Rabies Vaccines Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Inactivated Polio and Rabies Vaccines Market Size Forecast by Type
      10.6.1 Inactivated Polio Vaccine
      10.6.2 Inactivated Rabies Vaccine
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Inactivated Polio and Rabies Vaccines Market Size Forecast by Applications
      10.10.1 Pediatrics
      10.10.2 Adults
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Inactivated Polio and Rabies Vaccines Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Inactivated Polio and Rabies Vaccines Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Inactivated Polio and Rabies Vaccines Market Size Forecast by Type
      11.6.1 Inactivated Polio Vaccine
      11.6.2 Inactivated Rabies Vaccine
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Inactivated Polio and Rabies Vaccines Market Size Forecast by Applications
      11.10.1 Pediatrics
      11.10.2 Adults
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Inactivated Polio and Rabies Vaccines Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Inactivated Polio and Rabies Vaccines Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Inactivated Polio and Rabies Vaccines Market Size Forecast by Type
      12.6.1 Inactivated Polio Vaccine
      12.6.2 Inactivated Rabies Vaccine
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Inactivated Polio and Rabies Vaccines Market Size Forecast by Applications
      12.10.1 Pediatrics
      12.10.2 Adults
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Inactivated Polio and Rabies Vaccines Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Inactivated Polio and Rabies Vaccines Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Inactivated Polio and Rabies Vaccines Market Size Forecast by Type
      13.6.1 Inactivated Polio Vaccine
      13.6.2 Inactivated Rabies Vaccine
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Inactivated Polio and Rabies Vaccines Market Size Forecast by Applications
      13.10.1 Pediatrics
      13.10.2 Adults
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Inactivated Polio and Rabies Vaccines Market: Competitive Dashboard
   14.2 Global Inactivated Polio and Rabies Vaccines Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Bharat Biotech
      14.3.2 BIO-MED
      14.3.3 Serum Institute of India
      14.3.4 Kedrion Biopharma
      14.3.5 GlaxoSmithKline
      14.3.6 Merck
      14.3.7 Pfizer
      14.3.8 Bharat Biotech

Our Trusted Clients

Contact Us